SSA
AUPH icon

Schonfeld Strategic Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342K Buy
+20,124
New +$321K ﹤0.01% 1985
2026
Q1 		– Sell
-38,764
Closed -$618K – 2207
2025
Q4 		$618K Sell
38,764
-48,064
-55% -$681K ﹤0.01% 1315
2025
Q3 		$959K Buy
+86,828
New +$948K 0.01% 1388
2025
Q2 		– Sell
-69,144
Closed -$556K – 2037
2025
Q1 		$556K Buy
69,144
+14,144
+26% +$115K ﹤0.01% 1540
2024
Q4 		$494K Sell
55,000
-3,500
-6% -$28.6K ﹤0.01% 1410
2024
Q3 		$429K Buy
+58,500
New +$363K ﹤0.01% 1501
2022
Q4 		– Sell
-104,500
Closed -$787K – 2579
2022
Q3 		$787K Buy
104,500
+58,300
+126% +$505K 0.01% 1449
2022
Q2 		$465K Buy
+46,200
New +$516K ﹤0.01% 1405
2021
Q4 		– Sell
-51,900
Closed -$1.15M – 2132
2021
Q3 		$1.15M Buy
51,900
+24,500
+89% +$389K 0.01% 909
2021
Q2 		$355K Buy
27,400
+6,700
+32% +$85.3K ﹤0.01% 1365
2021
Q1 		$269K Buy
+20,700
New +$300K ﹤0.01% 1373
2020
Q4 		– Sell
-92,100
Closed -$1.36M – 1565
2020
Q3 		$1.36M Buy
+92,100
New +$1.33M 0.03% 619
2020
Q1 		– Sell
-312,268
Closed -$6.33M – 1138
2019
Q4 		$6.33M Buy
+312,268
New +$2.88M 0.15% 161

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schonfeld Strategic Advisors's AUPH Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 20,124 shares worth $342K. The stake represents ﹤0.01% of the portfolio and ranks #1985 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in AUPH as recently as Q4 2025.

Schonfeld Strategic Advisors first reported a position in AUPH in Q4 2019 and has held it in 13 quarters since. The position peaked at $6.33M in Q4 2019. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Schonfeld Strategic Advisors held 20,124 shares of Aurinia Pharmaceuticals worth $342K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1985 holding.
  • Schonfeld Strategic Advisors first reported a position in Aurinia Pharmaceuticals in Q4 2019 and has held it in 13 quarters since.
  • Schonfeld Strategic Advisors's Aurinia Pharmaceuticals position peaked at $6.33M in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.